Benzinga | Apr 30, 2021 07:12AM EDT

Citigroup Maintains Buy on DexCom, Raises Price Target to $488

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $480 to $488.